tiprankstipranks

Matthew Maxwell Donley Insider Profile

11 Followers
Matthew Maxwell Donley, COO at Aurinia Pharmaceuticals, holds 662.90K shares in Aurinia Pharmaceuticals (Ticker: AUPH), holds 36.98K shares in Sucampo Pharmaceuticals (Ticker: SCMP).
tipranks
Matthew Maxwell Donley

Matthew Maxwell Donley
Aurinia Pharmaceuticals (AUPH)
COO

Ranked #91,561 out of 108,921 Corporate Insiders

Profitable Transactions

25%
1 out of 4 Profitable Transactions

Average Return

-31.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$11M
100.00%
A breakdown of Matthew Maxwell Donley's holdings

Insider Roles

Aurinia Pharmaceuticals
(AUPH)
COO
Roles that Matthew Maxwell Donley holds in companies

Most Profitable Insider Trade

Stock:
Aurinia Pharmaceuticals
(AUPH)
Rating:Informative Sell
Date:Mar 04, 2022 - Mar 04, 2023
Return:+15.00%
The most profitable trade made by Matthew Maxwell Donley

Matthew Maxwell Donley's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Aurinia Pharmaceuticals
Feb 23, 2026
COO
Uninformative Sell
473.77K
$10.77M
SCMP
Sucampo Pharmaceuticals
Feb 13, 2018
Uninformative Sell
665.55K
$665.55K
List of latest transactions for each holding click on a transaction to see Matthew Maxwell Donley's performance on stock

Matthew Maxwell Donley insider profile FAQ

What is the percentage of profitable transactions made by Matthew Maxwell Donley?
The percentage of profitable transactions made by Matthew Maxwell Donley is 25%.
    What is the average return per transaction made by Matthew Maxwell Donley?
    The average return per transaction made by Matthew Maxwell Donley is -31.70%.
      What stocks does Matthew Maxwell Donley hold?
      Matthew Maxwell Donley holds: AUPH, SCMP stocks.
        What was Matthew Maxwell Donley’s latest transaction?
        Matthew Maxwell Donley latest transaction was an Uninformative Sell of $473.77K.
          What was Matthew Maxwell Donley's most profitable transaction?
          Matthew Maxwell Donley’s most profitable transaction was an Informative Sell of AUPH stock on March 4, 2022. The return on the trade was 15.00%.
            What is Matthew Maxwell Donley's role in Aurinia Pharmaceuticals?
            Matthew Maxwell Donley's role in Aurinia Pharmaceuticals is COO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.